Tranexamic Acid vs Hydroquinone for Dark Spots

Tranexamic acid and hydroquinone both act on dark spots through different mechanisms. Hydroquinone is a drug in the United States and sells only by prescription. Tranexamic acid has no approved topical drug product and sells over the counter. Published trials report comparable pigment scores, with fewer irritant reactions on tranexamic acid. That regulatory gap explains the shift.

What is the difference between tranexamic acid and hydroquinone?

The difference is legal before it is chemical. Hydroquinone is regulated as a drug. Topical tranexamic acid has no approved drug product and sells in cosmetics. They also interrupt pigment at different points. Hydroquinone acts on melanin synthesis directly. Tranexamic acid acts upstream, on the signal that switches pigment production on.

	Tranexamic acid	Hydroquinone
US status	No approved topical drug product. Sold as a cosmetic ingredient.	Drug. One approved product, prescription only.
How you get it	Over the counter, in serums and ampoules	Prescription from a licensed clinician
Mechanism	Blocks plasminogen binding to keratinocytes, reducing the signal to melanocytes	Inhibits melanin synthesis in the melanocyte
Strengths used in trials	2 percent to 5 percent topical	2 percent to 4 percent topical
Side effect of note	Mild irritation reported	Exogenous ochronosis, a gradual blue-black darkening of skin
Intended use window	Ongoing cosmetic use	Short-term only, per the approved label

The full breakdown of tranexamic acid in skincare covers the ingredient on its own. This article covers the comparison and the regulation.

Why is hydroquinone no longer sold over the counter?

A 2020 statute closed the loophole that kept it on shelves. Over-the-counter hydroquinone never held a final FDA monograph. It sat in an unfinished rulemaking for decades. One law converted that unfinished status into a hard stop.

In 2006 the FDA issued a proposed rule on these products. It proposes that they are not generally recognized as safe and effective. It also calls them misbranded. Hydroquinone was the only active ingredient ever proposed for that monograph. Upon a final rule, the FDA intends to treat every such product as a new drug. Each one would need an approved application. That proposal is on the record at 71 FR 51146 in the Federal Register.

The CARES Act of 2020 then reformed the over-the-counter drug system. One clause did the work. A drug ruled not-GRASE in a proposed rule is deemed a new drug. It is deemed misbranded too. It needs an approved application starting 180 days after 27 March 2020. That date lands on 23 September 2020. The clause is 21 U.S.C. 355h(a)(4).

Is hydroquinone banned in the United States?

No. Hydroquinone is not banned, and it is not unregulated either. It moved from an unfinished shelf category into the prescription drug system. A doctor can still prescribe it. A retailer cannot legally sell an over-the-counter version.

Federal drug records show exactly one approved application containing hydroquinone. It is Tri-Luma, NDA 021112, approved in January 2002. The label combines fluocinolone acetonide 0.01 percent, hydroquinone 4 percent and tretinoin 0.05 percent. Its FDA label on DailyMed indicates it for short-term treatment of moderate to severe facial melasma only.

That same label is explicit about limits. It states the product is not indicated for maintenance treatment, and that melasma usually recurs after you stop. Products sold online as over-the-counter hydroquinone sit outside this system.

How does tranexamic acid work on dark spots?

It interrupts a signal, not the pigment itself. Tranexamic acid is a lysine analogue that blocks plasminogen from binding to keratinocytes. Less plasmin means less of the inflammatory signalling that drives melanocytes to make pigment.

The 2026 literature review by AlJabr and colleagues in the Journal of Cosmetic Dermatology describes the pathway. UV exposure activates plasmin in keratinocytes. Plasmin raises arachidonic acid and prostaglandins, which push tyrosinase activity. Tyrosinase is the rate-limiting enzyme in melanin production. The review is open access on PubMed Central.

This is why tranexamic acid gets discussed for melasma specifically. Melasma has a vascular and inflammatory component. Read how melasma differs from ordinary hyperpigmentation before you decide which one you have.

How do the two compare in published trials?

Head-to-head trials report similar pigment scores and a gentler side effect profile for tranexamic acid. Sample sizes are small. Treat the pattern as a signal, not a settled answer.

Study	Design	Comparison	Duration	Reported result
Atefi et al., 2017	Randomized, double-blind, 60 women	Topical TXA 5% vs hydroquinone 2%	12 weeks	MASI fell in both groups. Difference between groups not significant.
Indian RCT, cited in AlJabr 2026	Randomized, 100 patients	Topical TXA 5% vs hydroquinone 3%	12 weeks	MASI reduction 27% vs about 26.7%. Higher tolerability on TXA.

The Atefi trial, published in Dermatologic Therapy (Heidelberg) and archived on PubMed Central, also logged side effects. No side effects appeared in the tranexamic acid group. Ten percent of the hydroquinone group reported erythema and skin irritation. Patient satisfaction ran 33.3 percent versus 6.7 percent.

These figures describe the study formulations named above. They do not describe re:tones products, and no re:tones product was tested in them.

Is topical tranexamic acid an approved drug in the US?

No. Every tranexamic acid product the FDA has approved is oral or injectable. A search of the federal drug application database returns 35 product records in August 2026. Ten are tablets, and 25 are injections or intravenous solutions. None is topical.

The approved oral and injectable products treat bleeding, not pigment. Cyklokapron, for example, is indicated for short-term use in hemophilia patients around tooth extraction. Nothing in that set covers melasma or dark spots.

Topical tranexamic acid in a serum is therefore sold as a cosmetic. That is an honest description, not a demotion. A cosmetic works on appearance. It does not treat a disease, and no cosmetic should claim to.

What are the side effects of each ingredient?

Hydroquinone carries one distinctive risk. Tranexamic acid mostly carries irritation risk. The gap in severity is the main reason formulators moved.

The Tri-Luma label warns that hydroquinone may produce exogenous ochronosis. The label describes it as a gradual blue-black darkening of the skin. Its appearance should prompt stopping treatment. The label notes most affected patients are Black, and that it also occurs in Caucasian and Hispanic patients. A prescription puts a clinician between you and that risk.

Topical tranexamic acid studies report mild irritation and no systemic effects. Oral tranexamic acid is a different matter and belongs with a doctor. Reported effects there include gastrointestinal upset, headache and menstrual irregularity.

Why concentration alone does not settle the question

A percentage on a carton describes the bottle, not your skin. Your outer layer exists to keep things out, and it is good at the job. World Health Organization guidance on skin physiology puts the stratum corneum at 10 to 20 micrometres thick. It names that layer as the barrier to percutaneous absorption.

That is the whole argument this brand runs on. Our explainer on the stratum corneum and our piece on transdermal delivery go deeper. The short version sits on our science page.

Microneedling opens temporary channels through that layer. Those channels close. Gupta and colleagues at Georgia Tech measured the timing in human subjects using impedance spectroscopy. Unoccluded sites recovered barrier properties within two hours, per their 2011 paper in the Journal of Controlled Release.

Our 02 re:clear-T ampoule holds tranexamic acid at 5 percent, or 50,000 ppm, plus niacinamide at 2 percent. The trials above tested other formulations, not this one. Niacinamide works on a separate step. It inhibits melanosome transfer from melanocytes to keratinocytes. Hakozaki and colleagues describe this in the International Journal of Cosmetic Science, 2026. The vial is crimp-sealed medical glass. You open it. We make no promise about your result.

Safety, and who should skip this entirely

Start shallow. Set the depth collar at 0.5 mm and stay there for your first sessions. Use the PRO-R Nano cartridge at 15 micrometres, the forgiving one. Move deeper only after your skin has told you it is fine. Once a week is the ceiling, not the floor.

Skip microneedling entirely if any of these apply. Active acne, cold sores or any infection in the area. Eczema, psoriasis or rosacea flaring on the treatment site. A history of keloid scarring. Recent oral isotretinoin. Pregnancy or breastfeeding. Blood clotting disorders, or anticoagulant medication. Sunburn, or any broken skin. Ask a clinician if you are unsure.

Never put a prescription drug through a microchannel. That includes hydroquinone, tretinoin and Tri-Luma. Acids, retinol, vitamin C and fragrance also stay off freshly needled skin. Our guides on aftercare, side effects and who should not microneedle spell out the rest. Wear sunscreen daily with either ingredient.

Frequently asked questions

Can you use tranexamic acid and hydroquinone together?

Trials in the AlJabr review combine them, and report better pigment scores than hydroquinone alone. Hydroquinone requires a prescription in the United States, so this is a decision for your clinician. Do not assemble a combination yourself from products bought online. Ask the person who wrote the prescription.

What replaced hydroquinone on US shelves?

Several cosmetic ingredients absorbed the demand. Parikh and Ogunleye tracked US search interest from 2012 to 2023 in the Journal of Cosmetic Dermatology. Tranexamic acid led all skin-lightening ingredients at a search volume index of 5631, ahead of hydroquinone at 2415. Read the 2024 research letter. None of these is a drug replacement.

How long does tranexamic acid take to show a difference?

Published melasma trials run 12 weeks and report early changes around week four to eight. Pigment turns over slowly, and your outer layer replaces itself over weeks. Our guide on how long skincare takes to work covers the timeline in detail.

What percentage of tranexamic acid do studies use?

Topical trials typically use 2 percent to 5 percent. Intradermal studies inject 4 to 50 mg per mL. Higher is not automatically better, and irritation rises with concentration on compromised skin. Our note on what ppm means explains why 5 percent equals 50,000 ppm.

Is tranexamic acid safe during pregnancy?

We cannot answer that for you, and neither can a product page. Topical use in pregnancy is not well established in the literature. Oral tranexamic acid is a prescription medicine with clotting considerations. Ask your obstetrician or dermatologist before using either form.

Can you still buy hydroquinone online legally?

Prescription hydroquinone is legal when a licensed clinician prescribes it. Products marketed online as over-the-counter hydroquinone fall outside the approved drug system under 21 U.S.C. 355h. Strength, purity and labelling in that grey market are not verified by anyone.

Does tranexamic acid cause purging?

Purging follows ingredients that speed cell turnover. Retinoids and exfoliating acids do that. Tranexamic acid does not. Breakouts after starting a new serum usually point to a different ingredient or to irritation. See our piece on microneedling and skin purging for the distinction.

Is the device required to use a tranexamic acid ampoule?

No. You can apply the ampoule with clean hands like any serum. The re:tones Tap Pen exists to open a temporary route through the outer layer. Both halves are sold separately, and the ampoule is a complete product on its own.

Last updated: 20 August 2026. Reviewed against FDA drug records, the Federal Register and peer-reviewed literature cited above.

This article is general information about cosmetic ingredients and a cosmetic device. It is not medical advice. re:tones products do not diagnose, treat, cure or prevent any disease. Talk to a licensed clinician about melasma, persistent dark spots or any prescription treatment.